QTRX Quanterix Corporation
$2.89▲ +2.12%
Healthcare
Other
After hours
$2.89▲ +0.00%
Oct 27, 4:01 PM ET
Volume 467.0K
Avg Volume (10D) 430.1K
Key Metrics & Fundamentals
Market Cap
$136.68M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.15 - 8.77
% vs 50 MA
-3.01%
% vs 200 MA
-26.50%
RSI-14
44.4
MACD Histogram
-0.0400
Beta (1Y vs SPY)
1.89
Free Cash Flow
-$5.22M
Gross Rev
$32.91M
Gross Profit
$12.67M
EBITDA
$12.25M
COGS
$20.23M
Operating Exp
$35.17M
Operating Income
-$22.50M
EBIT
-$22.50M
Pretax Income
-$48.99M
Net Income
-$48.93M
EPS (Diluted)
-1.04
Price & Volume History
Loading chart…
Recent News
ALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer's Disease Biomarker Research
PR Newswire · Oct 7, 2026 8:30 AM ET
/C O R R E C T I O N -- ALZpath, Inc./
PR Newswire · Oct 7, 2026 8:30 AM ET
Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals
Business Wire · Oct 7, 2026 8:00 AM ET
Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026
Business Wire · Sep 25, 2026 8:00 AM ET
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Sep 16, 2026 9:00 PM ET
Quanterix Names Dr. Yuri Fesko Chief Medical Officer
Business Wire · Sep 14, 2026 8:00 AM ET
Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share
GlobeNewswire · Sep 4, 2026 5:48 AM ET
Quanterix (QTRX) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 17, 2026 12:28 PM ET
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test
MarketBeat · Aug 16, 2026 2:02 PM ET
Quanterix Insider Bought Shares Worth $286,354, According to a Recent SEC Filing
MT Newswires · Aug 14, 2026 4:07 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See QTRX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.